Inhaled budesonide in the treatment of early COVID-19
The Lancet Respiratory Medicine in conversation with - Un pódcast de The Lancet Group
Categorías:
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
